AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Onconetix, Inc. Director's Dealing 2022

Feb 18, 2022

35411_dirs_2022-02-17_768fe3c3-fc9b-4e16-8073-1a3448db1e4e.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Blue Water Vaccines Inc. (BWV)
CIK: 0001782107
Period of Report: 2022-02-17

Reporting Person: Hernandez Joseph (CEO, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.00001 per share	3200000	Direct